iStar Medical SA
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From iStar Medical SA
Medtech Insight's Deal-Making column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics and Medical Devices – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in July 2022. Data provided by Biomedtracker.
The pharmaceutical company has made a bold play to expand its presence in the device space, giving iSTAR upfront cash in a deal that grants it the right to buy iSTAR for almost half a billion dollars.
MINIject has been approved in Europe for open-angle glaucoma patients.
iSTAR Medical reported six-month clinical trial data supporting its latest micro-invasive glaucoma surgery device, MINIject.
- Implantable Devices
Surgical Equipment & Devices
- Minimally or Less Invasive